Navigation Links
Pharmaceutical Pricing and Health Outcomes Top Trending News This Week from HealthEconomics.Com
Date:3/15/2013

Ponte Vedra Beach, FL (PRWEB) March 15, 2013

Top story: The top read story on HealthEconomics.Com was a blog posting on HealthEconomics.Com’s blog, tHEORetically Speaking, by Debra Gordon, MS, entitled “Pricing Cars Like Healthcare”. Medical procedures and therapeutic interventions provided by hospitals have vastly different price points, even for those patients who desire to pay out-of-pocket, and it is exceedingly hard to determine a price at all. Ms. Gordon compares this lack of price transparency within the healthcare sector with the ease of price comparison for common consumer goods, like automobiles or car-related parts. The issues associated with health policy and pricing are debated each week on the tHEORetically Speaking blog.

Another story in HealthEconomics.Com focused on the dilemma among the pharmaceutical industry C-Suite executives who believe that the constantly evolving business model among major payers and managed markets is a “pain point”, according to research by Cegedim discussed in a Medical Marketing & Media Leadership Exchange. The silo approach currently used by pharma to address payer issues results in separation between marketing, sales, and managed markets departments. This results in a lack of understanding, inconsistency of message, market access challenges, and resource waste. This organizational breakdown is also evident in the lack of a focused digital strategy by pharma for the payer audience. HealthEconomics.Com covered this important story, and provides in-depth strategies and tactics to the pharmaceutical industry to converse with the payer audience using a variety of digital means. (Original story sourced from Medical Marketing & Media Leadership Exchange: Pact With the Payer, Oct. 2012).

Another trending story on HealthEconomics.Com was by research analyst Sarah Ray, who blogged about International Reference Pricing and compared it to sibling rivalry. International price referencing relates to how countries around the world set the price (or, more commonly, the reimbursable price) of a drug product by evaluating the price of that product in various countries in their geographical region. Ms. Ray notes that this process is akin to siblings in their never-ending quests to ensure equality amongst themselves. The pharmaceutical industry is well-versed in the international pricing game, and uses a global launch sequence to determine the order in which they launch products around the world, maximizing their price points. A recent survey by Cutting Edge Information found that price referencing was the top consideration for 67% of surveyed companies, and of utmost importance to pharma executives.

About HealthEconomics.Com (http://www.healtheconomics.com): A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/TopNews/prweb10532217.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
2. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
3. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
4. ISPE Conference to Benchmark and Advance Quality by Design in the Biopharmaceutical Industry
5. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
6. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
7. AVANIR Pharmaceuticals To participate in two conferences in March
8. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
9. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
10. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
11. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Cancer diagnostics workflow solution ... its executive team to lead the development and commercialization of its Cancer Information ... the diagnosis and treatment of cancer. The CIDT addresses the need for curated ...
(Date:2/21/2017)... ... February 21, 2017 , ... Creation Technologies, ... solutions for original equipment manufacturers (OEMs) , today announced it has received the ... consecutive year winning in its category of electronics manufacturing services (EMS) providers with ...
(Date:2/21/2017)... -- Scientists From Two Companies to Accelerate ... ... STEER, creator of advanced materials platform technologies that ... plastics, pharmaceuticals, food and nutraceuticals, biomaterials and biorefining, today announced ... technology company, on creating co-rotating twin screw extruder technology ...
(Date:2/20/2017)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) announced today that ... Orecchioni, the company,s COO, has been named President, effective immediately.  ... years, Fabrice has overseen the construction, start-up and operation of the ... of the Mitsui JV.  Fabrice has also been extensively involved in ... ...
Breaking Biology Technology:
(Date:2/8/2017)... LONDON , Feb. 7, 2017 Report ... $12.5 billion by 2021 from $8.3 billion in 2016 ... from 2016 to 2021. Report Includes - An ... of global market trends, with data from 2015 and ... through 2021. - Segmentation of the market on the ...
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, ... a new report, Sensors for Robotics: Technologies, Markets and Forecasts ... ... Revenues ... "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force ...
Breaking Biology News(10 mins):